Federal Research Group Advances Colorado Team Following Successful Reversal of Osteoarthritis in Animals

A $33.5M federal project advances as Colorado researchers demonstrate that new injectable therapies can fully regenerate damaged joints within eight weeks.

By: AXL Media

Published: Apr 12, 2026, 1:48 PM EDT

Source: Information for this report was sourced from CU Boulder Today

A Multidisciplinary Breakthrough in Tissue Regeneration

A collaborative effort involving scientists from CU Boulder, CU Anschutz, and Colorado State University has successfully demonstrated a new suite of therapies capable of prompting damaged joints to self-repair. Under the leadership of Stephanie Bryant, a professor of chemical and biological engineering, the team utilized animal studies to show that osteoarthritis—a disease previously considered incurable—can be reversed in a matter of weeks. The project has met the rigorous milestones required to advance to the next phase of a $33.5 million funding agreement provided by the federal Advanced Research Projects Agency for Health (ARPA-H).

Dual Approach to Cartilage and Bone Restoration

The Colorado team is pursuing two distinct technological paths to address varying degrees of joint decay. The first involves a patented particle delivery system that provides intermittent bursts of an FDA-approved drug directly into the joint over several months. For more severe cases involving physical lesions, the researchers developed a "biomaterial repair kit" composed of engineered proteins. This cocktail is injected arthroscopically and cured in place, where it functions as a scaffold to recruit the body’s own progenitor cells to fill gaps in the cartilage or bone.

Rapid Recovery and Full Defect Repair

Results from the initial animal trials indicate a high level of efficacy for both methods. When treated with the regenerative injection, arthritic joints returned to a healthy state within a timeframe of four to eight weeks. Furthermore, the application of the protein patch to physical holes in cartilage and bone resulted in what Bryant described as "full regeneration and repair of the defect." These effects were also observed in human cells derived from patients who had undergone joint replacements, confirming a clear regenerative response across species.